New drug ABBV-1451 put to the test in healthy volunteers

This early-stage study is testing a new drug called ABBV-1451 in healthy adults to see how safe it is and how the body processes it. About 90 volunteers will receive a single dose, and researchers will monitor for side effects and measure drug levels in the blood. The study also includes Japanese and Han Chinese participants to check for any differences. No treatment benefit is expected—this is purely to gather safety and dosing information.